Mentice (MNTC) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
7 Apr, 2026Executive summary
Q4 net sales reached SEK 91 million, representing 18% organic growth (5% FX-adjusted), with full-year net sales at SEK 279 million, up 3% organically but negatively impacted by FX and macroeconomic uncertainty.
Q4 order intake was SEK 127 million, with 25% organic growth; full-year order intake grew 8% organically (2% FX-adjusted), driven by MDI customers, especially in Americas and APAC.
EBITDA margin improved to 25% in Q4 from 19% the previous year, supported by higher sales, cost-saving measures, and strategic realignment.
Strategic focus remains on expanding the MDI segment and improving the HCS business, with ongoing cost control and operational efficiency initiatives.
Board changes and a rights issue occurred, with Gulf Offshore Limited increasing its stake and consolidation of the simulation business to Denver completed.
Financial highlights
Q4 net sales: SEK 91 million (+18% organic); Americas led with 23% organic growth.
Q4 order intake: 126.8 MSEK (+25.3% organic, +16.6% YOY, -8.7% currency effect).
Q4 EBITDA: SEK 23 million (margin 25%), net income: SEK 13 million, EPS: 0.46 SEK.
Full year 2025 net sales: 279.1 MSEK (+3.4% organic, -3.9% YOY, -7.3% currency effect).
Operational cash flow was lower due to increased working capital and accounts receivables; cash at year-end: 33.4 MSEK.
Outlook and guidance
Entering 2026 with a strong project pipeline, improved cost structure, and strategic focus on MDI and HCS segments.
Cost base expected to remain stable in 2026, with only minor, revenue-linked investments and flat R&D as a percentage of sales.
Targeting 20–30% annual net sales growth and 20% EBITDA margin within three years.
Confidence in continued growth, especially in the Americas and MDI segment, with expectations for HCS segment improvement by end of 2026.
Macroeconomic uncertainty, currency volatility, and potential tariffs remain key challenges.
Latest events from Mentice
- Strong Q4 growth, expanded customer base, and focus on advanced simulation drive future outlook.MNTC
DNB Carnegie Healthcare Seminar 20269 Mar 2026 - Q3 sales fell nearly 10% year-over-year, but major new orders and APAC growth support the outlook.MNTC
Q3 202416 Jan 2026 - Q4 net sales up 22.4% with margin expansion, but full-year profit remained negative.MNTC
Q4 202424 Dec 2025 - Net sales up 19.5% year-over-year; losses and FX headwinds offset gains; strategic changes underway.MNTC
Q1 202520 Nov 2025 - Sales and order intake fell sharply, but restructuring and new clearances support future growth.MNTC
Q2 202516 Nov 2025 - Q3 revenue up 22% with margin gains, strong MDI growth, and improved net income.MNTC
Q3 20256 Nov 2025 - Record Q2 sales and profitability achieved, driven by strong APAC and Americas performance.MNTC
Q2 202413 Jun 2025